SlideShare ist ein Scribd-Unternehmen logo
1 von 60
Downloaden Sie, um offline zu lesen
PRESENTED BY
ROOMA KHALID
M.Phil pharmaceutics(2014-
2016)
Islamia University Bahawalpur
 Definition
 Objectives
 Indications
 Administration
 Formulation
 Compounding
 Documentation
 DEFINITION:
A method of feeding the patients by
infusing the mixture of all necessary
nutrients into the circulatory system, thus by
passing the GIT.
Also referred to as
Intravenous nutrition
Parental nutrition
 Parental nutrition is indicated generally
when there is severe gastro-intestinal
dysfunction (patients who cannot take
sufficient food or feeding formulas by enteral
route)
1:Central or total parental nutrition (TPN)
2:Peripheral parental nutrition (PPN)
1: CENTRAL OR TOTAL PARENTAL NUTRITION:
It is given via central
vein.central route is indicated when long
term feed is anticipated, high tonicity or
large volume formulations are required.
2: PERIPHERAL PARENTAL NUTRITION:
it is given via peripheral vein. It
is indicated for patients which require short
term feeding. Generally 900mOsmol/L is
maximum osmolarity tolerated by the
peripheral veins.
 For patients unable to tolerate any form of
enteral feeding, the administration of fluid
and nutrients via a parenteral route is
necessary.
 For long-term care a balanced diet
containing all the essential nutrients,
including vitamins and trace elements, must
be provided.
 To prevent unwanted weight loss and skin
break down, promoting positive nitrogen
balance and maintaining visceral and somatic
protein stores.
 Illness and injury promote catabolism and
hypermetabolism, so the patient is burning
calories faster to keep up with his body's
demands. If he doesn't get adequate
nutrition, his body will break down lean
muscle for glucose, which could slow healing
and prolong his recovery (Collins & Navarre,
2003).
 TPN reduces morbidity and mortality,
promotes tissue repair, and enhances the
immune response (Merck, n.d.)
 Johnston at al reported in 1978 that an
undernourished patient whose
gastrointestinal tract is temporarily or
permanently unusable can increase lean body
tissue and also lay down fat if fed a suitable
combination of nutrients intravenously.
 With an understanding of the clinical aspects
of TPN, pharmacists can recommend
regimens to fulfil the needs of the patient as
diagnosed by the physician.
 Possible interactions with concomintant
medication may be identified and advice
given on suitable administration systems.
TPN is considered necessary in following
conditions:
 Patients whose GIT tract is inaccessible, non
functional, perforated.
 Undernorished patients who cannot ingest
larger volumes of oral feedings and are being
prepared for surgery, radiation therapy, or
chemotherapy.
 Disorders requiring complete bowel rest e.g
ulcerative colitis
 Pediatric GI disorders e.g prolonged diarrhea
Powell-Tuck at al reported in 1978 a
technique for administration of the total
daily requirement for TPN via a single
container. This was a significant advance
over the multiple-bottle method of
administration. Three-litre bag therapy,
however, is not ideal for all patients.
In an intensive care unit, for example,
requirements for fluids and electrolytes may
change rapidly throughout the day and
require the careful titration that can only be
obtained with smaller volume fluids and
injections.
For short-term therapy rotation of peripheral
entry sites may provide a simple means of
administering TPN without the complications
of initiating central vein access. Silk at al
reported in 1983 that for longer-term
therapy a catheter placed into the superior
vena cava as being the safest method of
entry providing rapid dilution of the
hypertonic solution.
Adult TPN patients generally receive 2-3
litres of fluids per day. Rapid,uncontrolled
infusion of this amount of fluid would cause
renal overload and would be of no benefit to
the patient. It is thus vital that some form of
flow control device is employed. This may
range from simple clamps through to
electronic drip controllers.
 Once TPN has been initiated on a patient it is
essential that routine monitoring is carried
out. The clinical pharmacist should have an
understanding of the relevance of these
routine tests (particularly those such as 24-
hour urine analysis which is the main
determinant of nitrogen requirements) in
order to make adjustment to the TPN
formulation.
Parenteral nutrition solutions are complex
formulations that generally include energy
supplied as dextrose and fat, as well as
protein, electrolytes, trace
elements,vitamins, and water. These
components usually need to be individualized
for patients according to their primary
diagnosis, chronic diseases, fluid and
electrolyte balance,acid-base status, and
specific goals of parenteral nutrition.
1. NITROGEN:
The main objective of parental
nutrition is to supply the undernourished
patient with sufficient utilizable nitrogen to
re-establish nitrogen balance, i.e. where the
amount of nitrogen administered is
approximately equal to that excreted (mainly
as urea).
2.AMINO ACIDS:
The body’s relative requirements of the
individual amino acids is expected as follows:
 ESSENTIAL:
Which cannot be synthesized
by man. All the commercially available
solutions contain the eight essential amino
acids in varying proportions.
 NON ESSENTIAL AMINO ACIDS:
Those amino acids
which can normally be synthesized by the
body. These amino acids are used to increase
the amount of nitrogen available from the
solutions.
 SEMI ESSENTIAL AMINO ACIDS:
Those amino acids
which although they can in theory be
synthesized by the body, may occasionally
need to be provided in the TPN solution due
to the patient's age or disease state.
3.ENERGY MACRO NUTIENTS
DEXTROSE:
 Dextrose is the primary source of parenteral
carbohydrate.
 Dextrose is needed by the central nervous
system, white blood cells, red blood cells,
and renal medulla.
 Each gram of hydrated dextrose used in
parenteral nutrition yields 3.4 kcal.
 Parenteral nutrition solutions suitable for
peripheral vein administration have dextrose
concentrations of 10% or less.
 Parenteral nutrition solutions with final
concentrations of 10% or greater must be
administered by a central vein because of
the high osmolarity.
4. LIPIDS:
Administration of lipid emulsion on a
daily, twice or three times weekly basis
appears to provide a balanced mixture of
nutrients for the patient requiring long-term
feeding. Intravenous fat emulsions are used
in parenteral nutrition as an energy source
and to provide essential fatty acids.
Intravenous fat emulsions are particularly
beneficial as an energy source in patients
suffering from diabetes,stress, respiratory
acidosis, and hepatic steatosis.
5.ELECTROLYTES:
 Electrolytes in maintenance or therapeutic
doses need to be added daily to the
parenteral nutrition solution to preserve
electrolyte homeostasis.
 Each patient’s requirements for individual
electrolytes depend on the primary disease
state, renal function, hepatic function,
pharmacotherapy, past intake, renal or
extrarenal losses, and nutritional status.
 Sodium is of critical importance in the fluid
balance of both of healthy and sick subjects.
 Sodium losses and gains are generally
accompanied by similar shifts in chloride ions
and a consequent movement in water.
 Severe losses may lead to hypovolaemia,
circulatory failure and shock. Generally a
serum concentration of 135-145 mEq/litre is
throught to be normal.
 Potassium is essential for the normal
operation of the cell and is an important
determinant of cell membrane resting
potential.
 Thus abnormally high or low levels can result
in poor nerve impulse conduction,
fluctuations in heart rhythm and even death
due to heart failure.
 It also plays a vital role in distribution of
body water
 Absence of calcium from TPN in the long
term may produce symptoms of
hypocalcaemia such as muscle spasm and
numbness.
 The effect of lack of calcium on the growing
child on TPN could understandably have a
dramatic effect of growth and development
of bones and teeth.
Magnesium has many physiological actions.
The most clinically significant effects of
magnesium imbalance are associated with
changes in neuromuscular or cardiovascular
function.
 By virtue of its buffering action phosphate
helps maintain body acid-base balance.
 If phosphate is not provided in the TPN
solution hypophosphataemia may develop
which can give rise to impaired red blood
cell function of many organs.
 Hypophosphataemia may also be induced as
a result of infusion of high glucose loads.
 Trace elements are essential micronutrients
that are metabolic cofactors essential for the
proper functioning of several enzyme
systems.
 Zinc, Copper, Selenium, Chromium, Iron,
Manganese, Cobalt, Molybdenum.
 Zinc requirements are increased in metabolic
stress and in gastrointestinal disease
secondary to diarrheal diseases.
 Manganese and copper are excreted through
the biliary tract, whereas Zinc, and
selenium are excreted renally.
 Therefore, copper and manganese should be
used with caution in patients with
cholestatic liver disease.
 Selenium stores have been shown to be
depleted in patients receiving long-term
parenteral nutrition or in those with thermal
injury, acquired immunodeficiency
syndrome, or liver failure.
 Therefore, selenium should be added initially
to the parenteral nutrition solution for
patients with these disease states or
conditions.
7. VITAMINS
 Patients on long-term TPN therapy will
generally require some vitamin
supplementation.
 The commercial preparations of vitamins
available along with recommended daily
requirements which seem to vary according
to the current available recommendations.
 A Retinol
 B1 Thiamines
 B2 Riboflavine
 B6 Pyridoxine
 B12 Cyanocobalamin
 B Nicotinamide
 B Biotin
 B Pantothenic acid
 B Folic acid
 C Ascorbic acid
 D Calciferol
 E Tocopherol acetate
 K Phytomenadione
 Vitamins are an essential component of a
patient’s daily parenteral nutrition regimen
because they are necessary for normal
metabolism and cellular function of the
body.
 Individual parenteral vitamins are
recommended when the multivitamins
products are not available.
 Vitamins that are marketed as single-entity
parenteral formulations include
 vitamins A, D, E, K, B1 (thiamine), B2
(riboflavin), B3 (niacin), B6 (pyridoxine),
B9(folic acid), B12 (cyanocobalamin) , and C
(ascorbic acid).
8. FLUIDS
 In the human body, water is the predominant
chemical entity, generally accounting for
more than half of the total body weight.
 An inverse relationship exists between the
amount of body fat and the amount of body
water present in an individual.
 Total water gains and losses in the healthy
adult fall within the range of 1500-3000ml
daily.
 Thus, where the patient requires TPN, the
volume administered will fall into this range
and may need to be supplemented by
additional fluids in the special cases of
burns, etc.
 Careful patient monitoring is required to
ensure that they do not become dehydrated.
 Nutrients are mixed just prior to infusions,
by breaking the plastic connectors between
the compartments, then vitamins and trace
elements are added extemporaneously to the
bag.
 Shelf –life of these bags is at least 12
months, but allow only for standardized
formulas.
 The use of three-compartment TPN bags is
less expensive in terms of application costs
than separate bottles or hospital-
compounded bag systems.
 Because of the complexity of parenteral
nutrition products, safe preparation is a
complicated task.
 The quality of the final product depends on
the facilities, resources,personnel training
and products used in preparation.
 Since the inception of parenteral nutrition,
pharmacists have developed policies and
procedures for parenteral nutrition
compounding based on their training and
interpretation of the literature.
 Parenteral nutrition is considered a high-risk
sterile product. Its compounding includes
complex and/or numerous aseptic
manipulations.
 Specific guidelines for aseptic processing
include media fill validations of both the
process and the personnel carrying out the
process.
 There are specific requirements for facilities,
space and environmental control similar to
those of a Class 100 clean-room
environment.
 Sterile product release checks require visual
inspection against a lighted white and black
background for evidence of visible
particulates or other foreign matter.
 In addition,compounding accuracy checks of
the addition of all drug products or
ingredients used to prepare the parenteral
nutrition product are ensured by validating
the volume and quantity used in admixture.
 Presterilized disposable membrane filtration
devices, which are sensitive in detecting low
levels of contamination and easy to use, are
commercially available.
 The compounding of parenteral nutrition
admixtures accelerates the rate of
physicochemical destabilization, resulting in
the recommendation to administer
parenteral nutrition as soon after its
preparation as possible certain amino acids,
lipids, and multivitamins are most
susceptible to instability.
 Pharmacist involved in TPN should have a
thorough understanding of the potential
stability issues in these mixtures and be able
to advise physicians accordingly.
 In general the following information will be
required on the label:
 Patient name/number
 Ward
 Product constituents
 Batch (dispensing number)
 Expiry date/time
 Storage conditions
 Other instructions such as guidance on
administration rate or technique, limitations
on further additions etc., may also be
required.
 Once the product has been filled and
labelled a pharmacist should perform a final
check against the prescription prior to
sending the product to the ward.
 This check should include the patient’s
name, ward, etc. and should once again
compare the constituents requested against
the final label.
 Details of further additions, storage,
conditions, expiry date, etc. should also be
confirmed and the batch number or other
reference allocated should be checked to
facilitate traceability in the event of any
difficulties arising subsequent to dispensing,
e.g. precipitation, discoloration, etc.
 The hospital pharmacist may be involved in
development of nursing care guidelines with
particular reference to further additions,
storage, etc.
 It may also be useful for the ward
pharmacist to check that TPN is being
correctly administered to the patient, i.e.
with correct flow control device, away from
direct sunlight, etc.
 Allwood at al recommends in 1984 that
compounded TPN solutions should be stored
at 2-8˚C in light of both microbiological and
chemical considerations.
 Should not be stored at room temperature
for periods in excess of the 12-24 hours
required for administration.
 Where supplies of compounded product are
to be made to hospitals or home patients
away from the site of manufacture, the
quality of the packaging system to maintain
product temperature during transit should be
validated to the satisfaction of local quality
control standards.
 Insulated polystyrene containers may be
useful for this purpose.
 Providing a TPN compounding service within
a hospital may be a costly venture for the
pharmacy department.
 All the factors must be considered when
developing true service costs and deciding
whether to produce in house or obtain
product from a regional hospital or
commercial source.
 Bags made of poly-ethylene and poly-
vinylchloride and of the copolymer
ethylenevinylacetate were used as containers
of perfusion solutions for total parenteral
nutrition.
 Injectable solutions for Total Parenteral
Nutrition containing L-
aminoacids,electrolytes and glucose, are
commonly sold as medicinal specialities in
glass containers.
 Bags made of plastic materials such as
copolymer ethylene-vinylacetate (EVA), poly-
ethylene (PE) and poly-vinylchloride (PVC)
are being used more and more often in the
manufacture of containers of perfusion
solutions.
 A work sheet should be generated for each
TPN-dispensing activity to be carried out for
recording materials, patient name, label
details, etc.
 The format for such a work sheet should be
agreed between the production and quality
control departments of the hospital in
accordance with local policy.
 Prescribe the nutrient formulation
 Recognize the needs of individual patients.
 Modification in quantities according to
clinical situation of patients.
 Monitor the interactions among various
electrolytes and drugs affect TPN mixture.
 Assist the health care team in developing a
cost effective formulary of nutrition
products.

Más contenido relacionado

Was ist angesagt?

Total Parenteral Nutrition : Types, Preparation, Indication and Complications
Total Parenteral Nutrition : Types, Preparation, Indication and ComplicationsTotal Parenteral Nutrition : Types, Preparation, Indication and Complications
Total Parenteral Nutrition : Types, Preparation, Indication and ComplicationsChetan Ganteppanavar
 
Total prentral nutrition
Total prentral nutritionTotal prentral nutrition
Total prentral nutritionIrfan Ahmed
 
Parenteral Nutrition Web
Parenteral Nutrition  WebParenteral Nutrition  Web
Parenteral Nutrition WebRia Pineda
 
Total parenteral nutrition(TPN)
Total parenteral nutrition(TPN)Total parenteral nutrition(TPN)
Total parenteral nutrition(TPN)Armin Eisazaei
 
Total Parenteral Nutrition
Total Parenteral NutritionTotal Parenteral Nutrition
Total Parenteral Nutritionrakshamhetre
 
Total parenteral nutrition
Total parenteral nutritionTotal parenteral nutrition
Total parenteral nutritionVenkatesh Kolla
 
Total Parentral Nutrition-Hospital Pharmacy
Total Parentral Nutrition-Hospital PharmacyTotal Parentral Nutrition-Hospital Pharmacy
Total Parentral Nutrition-Hospital PharmacyRiya Mariam
 
Total parental nutrition
Total parental nutritionTotal parental nutrition
Total parental nutritionBe Akash Sah
 
Total parenteral nutrition in brief
Total parenteral nutrition in briefTotal parenteral nutrition in brief
Total parenteral nutrition in briefISRAR UDDIN
 
Total parenteral nutrition ( TPN )
Total parenteral nutrition ( TPN )Total parenteral nutrition ( TPN )
Total parenteral nutrition ( TPN )rohini sane
 
Administering TPN
Administering TPNAdministering TPN
Administering TPNsilex13
 
Parenteral nutrition therapy
Parenteral nutrition therapyParenteral nutrition therapy
Parenteral nutrition therapyJoginder Singh
 

Was ist angesagt? (20)

Tpn vs ppn
Tpn vs ppnTpn vs ppn
Tpn vs ppn
 
Total Parenteral Nutrition : Types, Preparation, Indication and Complications
Total Parenteral Nutrition : Types, Preparation, Indication and ComplicationsTotal Parenteral Nutrition : Types, Preparation, Indication and Complications
Total Parenteral Nutrition : Types, Preparation, Indication and Complications
 
Total prentral nutrition
Total prentral nutritionTotal prentral nutrition
Total prentral nutrition
 
Parenteral Nutrition Web
Parenteral Nutrition  WebParenteral Nutrition  Web
Parenteral Nutrition Web
 
Total parenteral nutrition(TPN)
Total parenteral nutrition(TPN)Total parenteral nutrition(TPN)
Total parenteral nutrition(TPN)
 
Total Parenteral Nutrition
Total Parenteral NutritionTotal Parenteral Nutrition
Total Parenteral Nutrition
 
Enteral nutrition method
Enteral nutrition methodEnteral nutrition method
Enteral nutrition method
 
Tpn
TpnTpn
Tpn
 
Total parenteral nutrition
Total parenteral nutritionTotal parenteral nutrition
Total parenteral nutrition
 
Total Parentral Nutrition-Hospital Pharmacy
Total Parentral Nutrition-Hospital PharmacyTotal Parentral Nutrition-Hospital Pharmacy
Total Parentral Nutrition-Hospital Pharmacy
 
Total parental nutrition
Total parental nutritionTotal parental nutrition
Total parental nutrition
 
Total parenteral nutrition in brief
Total parenteral nutrition in briefTotal parenteral nutrition in brief
Total parenteral nutrition in brief
 
Total parenteral nutrition ( TPN )
Total parenteral nutrition ( TPN )Total parenteral nutrition ( TPN )
Total parenteral nutrition ( TPN )
 
Intravenous infusion
Intravenous infusionIntravenous infusion
Intravenous infusion
 
Administering TPN
Administering TPNAdministering TPN
Administering TPN
 
Total parental nutrition
Total parental nutrition   Total parental nutrition
Total parental nutrition
 
Parenteral nutrition therapy
Parenteral nutrition therapyParenteral nutrition therapy
Parenteral nutrition therapy
 
Medication errors ppt
Medication errors pptMedication errors ppt
Medication errors ppt
 
Enteral nutrition
Enteral nutritionEnteral nutrition
Enteral nutrition
 
Drug Administration
Drug AdministrationDrug Administration
Drug Administration
 

Andere mochten auch

Total parenteral nutrition
Total parenteral nutritionTotal parenteral nutrition
Total parenteral nutritionJitendra Shukla
 
Total parentral nutrition
Total parentral nutritionTotal parentral nutrition
Total parentral nutritionsania2014
 
Pharmaceutical mgt and formulary
Pharmaceutical mgt and formularyPharmaceutical mgt and formulary
Pharmaceutical mgt and formularyTWAHA KABANDIKA
 
IV Lecture
IV LectureIV Lecture
IV Lecturecwilli15
 
Total parenteral nutrition
Total parenteral nutritionTotal parenteral nutrition
Total parenteral nutritionvora kun
 
L&E Chapter 003 Lo
L&E Chapter 003 LoL&E Chapter 003 Lo
L&E Chapter 003 Loguestd9a398
 
Lect 5 cannulation students
Lect 5 cannulation studentsLect 5 cannulation students
Lect 5 cannulation studentsAli Mohamed Aziz
 
Neonatal Parenteral Feeding Dr.allam abuhamda Consultant of Pediatrics Neona...
 Neonatal Parenteral Feeding Dr.allam abuhamda Consultant of Pediatrics Neona... Neonatal Parenteral Feeding Dr.allam abuhamda Consultant of Pediatrics Neona...
Neonatal Parenteral Feeding Dr.allam abuhamda Consultant of Pediatrics Neona...palpeds
 
Short Bowel syndrome
Short Bowel syndromeShort Bowel syndrome
Short Bowel syndromefitango
 
Detailed study of the equipments as per sch m
Detailed study of the equipments as per sch mDetailed study of the equipments as per sch m
Detailed study of the equipments as per sch mDr. Shreeraj Shah
 
Clinical Pharmacokinetics-II [dosing of drugs, tdm]
Clinical Pharmacokinetics-II [dosing of drugs, tdm]Clinical Pharmacokinetics-II [dosing of drugs, tdm]
Clinical Pharmacokinetics-II [dosing of drugs, tdm]BADAR UDDIN UMAR
 
Intestinal failure and Short bowel syndrome in children
Intestinal failure and Short bowel syndrome in childrenIntestinal failure and Short bowel syndrome in children
Intestinal failure and Short bowel syndrome in childrenVernon Pashi
 
40088847 intravenous-therapy
40088847 intravenous-therapy40088847 intravenous-therapy
40088847 intravenous-therapyVincent Villaruz
 

Andere mochten auch (20)

Total parenteral nutrition
Total parenteral nutritionTotal parenteral nutrition
Total parenteral nutrition
 
Total parental nutrition
Total parental nutrition Total parental nutrition
Total parental nutrition
 
Total parenteral nutrition
Total parenteral nutritionTotal parenteral nutrition
Total parenteral nutrition
 
Peds TPN 2010
Peds TPN  2010Peds TPN  2010
Peds TPN 2010
 
Parentral nutrition
Parentral nutritionParentral nutrition
Parentral nutrition
 
Total parentral nutrition
Total parentral nutritionTotal parentral nutrition
Total parentral nutrition
 
Pharmaceutical mgt and formulary
Pharmaceutical mgt and formularyPharmaceutical mgt and formulary
Pharmaceutical mgt and formulary
 
IV Lecture
IV LectureIV Lecture
IV Lecture
 
Total parenteral nutrition
Total parenteral nutritionTotal parenteral nutrition
Total parenteral nutrition
 
Pk2
Pk2Pk2
Pk2
 
L&E Chapter 003 Lo
L&E Chapter 003 LoL&E Chapter 003 Lo
L&E Chapter 003 Lo
 
Lect 5 cannulation students
Lect 5 cannulation studentsLect 5 cannulation students
Lect 5 cannulation students
 
Neonatal Parenteral Feeding Dr.allam abuhamda Consultant of Pediatrics Neona...
 Neonatal Parenteral Feeding Dr.allam abuhamda Consultant of Pediatrics Neona... Neonatal Parenteral Feeding Dr.allam abuhamda Consultant of Pediatrics Neona...
Neonatal Parenteral Feeding Dr.allam abuhamda Consultant of Pediatrics Neona...
 
7. tpn for critically ill patients
7. tpn  for critically ill patients7. tpn  for critically ill patients
7. tpn for critically ill patients
 
Short Bowel syndrome
Short Bowel syndromeShort Bowel syndrome
Short Bowel syndrome
 
Detailed study of the equipments as per sch m
Detailed study of the equipments as per sch mDetailed study of the equipments as per sch m
Detailed study of the equipments as per sch m
 
Clinical Pharmacokinetics-II [dosing of drugs, tdm]
Clinical Pharmacokinetics-II [dosing of drugs, tdm]Clinical Pharmacokinetics-II [dosing of drugs, tdm]
Clinical Pharmacokinetics-II [dosing of drugs, tdm]
 
Intestinal failure and Short bowel syndrome in children
Intestinal failure and Short bowel syndrome in childrenIntestinal failure and Short bowel syndrome in children
Intestinal failure and Short bowel syndrome in children
 
Parenteral fluid therapy
Parenteral fluid therapyParenteral fluid therapy
Parenteral fluid therapy
 
40088847 intravenous-therapy
40088847 intravenous-therapy40088847 intravenous-therapy
40088847 intravenous-therapy
 

Ähnlich wie TOTAL PARENTAL NUTRITION

Type of Formula in Parenteral Nutrition.pptx
Type of Formula in Parenteral Nutrition.pptxType of Formula in Parenteral Nutrition.pptx
Type of Formula in Parenteral Nutrition.pptxAreebWaheed
 
Parenteral Nutrition - Monitoring and Guidelines
Parenteral Nutrition - Monitoring and GuidelinesParenteral Nutrition - Monitoring and Guidelines
Parenteral Nutrition - Monitoring and GuidelinesImaginative Brain Science
 
Nutrition in Acute Pancreatitis (According to ESPEN guidelines 2002 and ACG g...
Nutrition in Acute Pancreatitis (According to ESPEN guidelines 2002 and ACG g...Nutrition in Acute Pancreatitis (According to ESPEN guidelines 2002 and ACG g...
Nutrition in Acute Pancreatitis (According to ESPEN guidelines 2002 and ACG g...Jibran Mohsin
 
Parenteralandenteralfeeding or Total parentral nutrition
Parenteralandenteralfeeding or Total parentral nutritionParenteralandenteralfeeding or Total parentral nutrition
Parenteralandenteralfeeding or Total parentral nutritionjinsigeorge
 
Git nutrition1.
Git nutrition1.Git nutrition1.
Git nutrition1.Shaikhani.
 
total parenteral nutrition
total parenteral nutritiontotal parenteral nutrition
total parenteral nutritionBilalzaibZaib
 
parenteral and enteral nutrition
parenteral and enteral nutritionparenteral and enteral nutrition
parenteral and enteral nutritionShima Ghavimi, MD
 
ROLE OF NUTRITION IN SURGERY.pptx
ROLE OF NUTRITION IN SURGERY.pptxROLE OF NUTRITION IN SURGERY.pptx
ROLE OF NUTRITION IN SURGERY.pptxDrPradnya3
 
Prevention and treatment of protein energy wasting in
Prevention and treatment of protein energy wasting inPrevention and treatment of protein energy wasting in
Prevention and treatment of protein energy wasting inDr Ritesh kumar banode
 
Nutrition & drug dosing in dialysis patient
Nutrition & drug dosing  in dialysis patientNutrition & drug dosing  in dialysis patient
Nutrition & drug dosing in dialysis patientPabitra Thapa
 
Nutritional support in surgical patients
Nutritional support in surgical patientsNutritional support in surgical patients
Nutritional support in surgical patientsOmarAlaidaroos3
 
Parenteral Nutrition for the oral and maxillofacial surgery patient
 Parenteral Nutrition for the oral and maxillofacial surgery patient Parenteral Nutrition for the oral and maxillofacial surgery patient
Parenteral Nutrition for the oral and maxillofacial surgery patientMaxfac Center
 
Nutrition support sin weng lam
Nutrition support sin weng lamNutrition support sin weng lam
Nutrition support sin weng lamjim kuok
 
Special nutritional support (feeding methods).pptx
Special nutritional support (feeding methods).pptxSpecial nutritional support (feeding methods).pptx
Special nutritional support (feeding methods).pptxSowmya Jaiswal
 
NUTRITIONAL MANAGEMENT FOR FASTER RECOVERY.pptx
NUTRITIONAL MANAGEMENT FOR FASTER RECOVERY.pptxNUTRITIONAL MANAGEMENT FOR FASTER RECOVERY.pptx
NUTRITIONAL MANAGEMENT FOR FASTER RECOVERY.pptxsahithireddy272304
 

Ähnlich wie TOTAL PARENTAL NUTRITION (20)

Type of Formula in Parenteral Nutrition.pptx
Type of Formula in Parenteral Nutrition.pptxType of Formula in Parenteral Nutrition.pptx
Type of Formula in Parenteral Nutrition.pptx
 
Parenteral Nutrition - Monitoring and Guidelines
Parenteral Nutrition - Monitoring and GuidelinesParenteral Nutrition - Monitoring and Guidelines
Parenteral Nutrition - Monitoring and Guidelines
 
Nutrition in Acute Pancreatitis (According to ESPEN guidelines 2002 and ACG g...
Nutrition in Acute Pancreatitis (According to ESPEN guidelines 2002 and ACG g...Nutrition in Acute Pancreatitis (According to ESPEN guidelines 2002 and ACG g...
Nutrition in Acute Pancreatitis (According to ESPEN guidelines 2002 and ACG g...
 
Parenteralandenteralfeeding or Total parentral nutrition
Parenteralandenteralfeeding or Total parentral nutritionParenteralandenteralfeeding or Total parentral nutrition
Parenteralandenteralfeeding or Total parentral nutrition
 
Git nutrition1.
Git nutrition1.Git nutrition1.
Git nutrition1.
 
total parenteral nutrition
total parenteral nutritiontotal parenteral nutrition
total parenteral nutrition
 
Nutrition in icu
Nutrition in icuNutrition in icu
Nutrition in icu
 
parenteral and enteral nutrition
parenteral and enteral nutritionparenteral and enteral nutrition
parenteral and enteral nutrition
 
ROLE OF NUTRITION IN SURGERY.pptx
ROLE OF NUTRITION IN SURGERY.pptxROLE OF NUTRITION IN SURGERY.pptx
ROLE OF NUTRITION IN SURGERY.pptx
 
Prevention and treatment of protein energy wasting in
Prevention and treatment of protein energy wasting inPrevention and treatment of protein energy wasting in
Prevention and treatment of protein energy wasting in
 
Nutrition
NutritionNutrition
Nutrition
 
Tpn rajesh
Tpn rajeshTpn rajesh
Tpn rajesh
 
Nutrition & drug dosing in dialysis patient
Nutrition & drug dosing  in dialysis patientNutrition & drug dosing  in dialysis patient
Nutrition & drug dosing in dialysis patient
 
Total parenteral nutrition
Total parenteral nutritionTotal parenteral nutrition
Total parenteral nutrition
 
Nutritional support in surgical patients
Nutritional support in surgical patientsNutritional support in surgical patients
Nutritional support in surgical patients
 
Parenteral Nutrition for the oral and maxillofacial surgery patient
 Parenteral Nutrition for the oral and maxillofacial surgery patient Parenteral Nutrition for the oral and maxillofacial surgery patient
Parenteral Nutrition for the oral and maxillofacial surgery patient
 
Nutrition support sin weng lam
Nutrition support sin weng lamNutrition support sin weng lam
Nutrition support sin weng lam
 
Special nutritional support (feeding methods).pptx
Special nutritional support (feeding methods).pptxSpecial nutritional support (feeding methods).pptx
Special nutritional support (feeding methods).pptx
 
NUTRITIONAL MANAGEMENT FOR FASTER RECOVERY.pptx
NUTRITIONAL MANAGEMENT FOR FASTER RECOVERY.pptxNUTRITIONAL MANAGEMENT FOR FASTER RECOVERY.pptx
NUTRITIONAL MANAGEMENT FOR FASTER RECOVERY.pptx
 
Rrt
RrtRrt
Rrt
 

Último

SGK VIÊM KHỚP DẠNG THẤP YHN .pdf
SGK VIÊM KHỚP DẠNG THẤP YHN              .pdfSGK VIÊM KHỚP DẠNG THẤP YHN              .pdf
SGK VIÊM KHỚP DẠNG THẤP YHN .pdfHongBiThi1
 
Histology of lymph node(lymph node histology)
Histology of lymph node(lymph node histology)Histology of lymph node(lymph node histology)
Histology of lymph node(lymph node histology)pranavguleria2
 
Ovarian tumors Lecture notes for MBBS.pptx
Ovarian tumors Lecture notes for MBBS.pptxOvarian tumors Lecture notes for MBBS.pptx
Ovarian tumors Lecture notes for MBBS.pptxSizan Thapa
 
The Art and the Science of UK General Practice A historical review and timeli...
The Art and the Science of UK General Practice A historical review and timeli...The Art and the Science of UK General Practice A historical review and timeli...
The Art and the Science of UK General Practice A historical review and timeli...JakeMatthews12
 
Explaining "pathology" in digital pathology
Explaining "pathology" in digital pathologyExplaining "pathology" in digital pathology
Explaining "pathology" in digital pathologyYves Sucaet
 
INTRODUCTION TO THE FORENSIC SCIENCE.ppt
INTRODUCTION TO THE FORENSIC SCIENCE.pptINTRODUCTION TO THE FORENSIC SCIENCE.ppt
INTRODUCTION TO THE FORENSIC SCIENCE.pptKavitha Krishnan
 
Brief introduction to information ecosystem x public health.pptx
Brief introduction to information ecosystem x public health.pptxBrief introduction to information ecosystem x public health.pptx
Brief introduction to information ecosystem x public health.pptxTina Purnat
 
TARGET DELINEATION IN RECTUM CANCER BY DR KANHU
TARGET DELINEATION IN RECTUM  CANCER BY DR KANHUTARGET DELINEATION IN RECTUM  CANCER BY DR KANHU
TARGET DELINEATION IN RECTUM CANCER BY DR KANHUKanhu Charan
 
bleeding disorders 1 Dr.Nannika Pradhan
bleeding disorders 1  Dr.Nannika Pradhanbleeding disorders 1  Dr.Nannika Pradhan
bleeding disorders 1 Dr.Nannika Pradhanthesalberry
 
HERPES SIMPLEX VIRUS 12032019 TUESDAY pptx
HERPES SIMPLEX VIRUS 12032019 TUESDAY  pptxHERPES SIMPLEX VIRUS 12032019 TUESDAY  pptx
HERPES SIMPLEX VIRUS 12032019 TUESDAY pptxPulkitMittal54
 
Neutraceuticals, Herb-drug & Herb-food inetractions
Neutraceuticals, Herb-drug & Herb-food inetractionsNeutraceuticals, Herb-drug & Herb-food inetractions
Neutraceuticals, Herb-drug & Herb-food inetractionsPradnya Wadekar
 
Methicillin-resistant Staphylococcus Aureus (MRSA)
Methicillin-resistant Staphylococcus Aureus (MRSA)Methicillin-resistant Staphylococcus Aureus (MRSA)
Methicillin-resistant Staphylococcus Aureus (MRSA)Ahmad Thanin
 
Ten lessons learnt as anesthetist.pptx
Ten  lessons  learnt as anesthetist.pptxTen  lessons  learnt as anesthetist.pptx
Ten lessons learnt as anesthetist.pptxtusharchokshi1
 
Substance use disorder (drug addict ), Addiction
Substance use disorder (drug addict ), AddictionSubstance use disorder (drug addict ), Addiction
Substance use disorder (drug addict ), AddictionZeinabEmad3
 
Ayurveda research in Hypothyroidism, P
Ayurveda  research  in Hypothyroidism, PAyurveda  research  in Hypothyroidism, P
Ayurveda research in Hypothyroidism, PDr.Shalu Jain
 
Tracheostomy .pdf ENT by QuickMedTALK. getting things done on time
Tracheostomy .pdf ENT by QuickMedTALK. getting things done on timeTracheostomy .pdf ENT by QuickMedTALK. getting things done on time
Tracheostomy .pdf ENT by QuickMedTALK. getting things done on timeQuick MedTalk
 
Cholesterol Biosynthesis and catabolism for MBBS, Lab. MEd. BDS.pptx
Cholesterol Biosynthesis  and catabolism for MBBS, Lab. MEd. BDS.pptxCholesterol Biosynthesis  and catabolism for MBBS, Lab. MEd. BDS.pptx
Cholesterol Biosynthesis and catabolism for MBBS, Lab. MEd. BDS.pptxRajendra Dev Bhatt
 
EMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdf
EMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdfEMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdf
EMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdfMayuriGamit2
 

Último (20)

SGK VIÊM KHỚP DẠNG THẤP YHN .pdf
SGK VIÊM KHỚP DẠNG THẤP YHN              .pdfSGK VIÊM KHỚP DẠNG THẤP YHN              .pdf
SGK VIÊM KHỚP DẠNG THẤP YHN .pdf
 
Histology of lymph node(lymph node histology)
Histology of lymph node(lymph node histology)Histology of lymph node(lymph node histology)
Histology of lymph node(lymph node histology)
 
Ovarian tumors Lecture notes for MBBS.pptx
Ovarian tumors Lecture notes for MBBS.pptxOvarian tumors Lecture notes for MBBS.pptx
Ovarian tumors Lecture notes for MBBS.pptx
 
The Art and the Science of UK General Practice A historical review and timeli...
The Art and the Science of UK General Practice A historical review and timeli...The Art and the Science of UK General Practice A historical review and timeli...
The Art and the Science of UK General Practice A historical review and timeli...
 
Explaining "pathology" in digital pathology
Explaining "pathology" in digital pathologyExplaining "pathology" in digital pathology
Explaining "pathology" in digital pathology
 
INTRODUCTION TO THE FORENSIC SCIENCE.ppt
INTRODUCTION TO THE FORENSIC SCIENCE.pptINTRODUCTION TO THE FORENSIC SCIENCE.ppt
INTRODUCTION TO THE FORENSIC SCIENCE.ppt
 
Brief introduction to information ecosystem x public health.pptx
Brief introduction to information ecosystem x public health.pptxBrief introduction to information ecosystem x public health.pptx
Brief introduction to information ecosystem x public health.pptx
 
TARGET DELINEATION IN RECTUM CANCER BY DR KANHU
TARGET DELINEATION IN RECTUM  CANCER BY DR KANHUTARGET DELINEATION IN RECTUM  CANCER BY DR KANHU
TARGET DELINEATION IN RECTUM CANCER BY DR KANHU
 
bleeding disorders 1 Dr.Nannika Pradhan
bleeding disorders 1  Dr.Nannika Pradhanbleeding disorders 1  Dr.Nannika Pradhan
bleeding disorders 1 Dr.Nannika Pradhan
 
Oral disorders .pptx
Oral disorders .pptxOral disorders .pptx
Oral disorders .pptx
 
HERPES SIMPLEX VIRUS 12032019 TUESDAY pptx
HERPES SIMPLEX VIRUS 12032019 TUESDAY  pptxHERPES SIMPLEX VIRUS 12032019 TUESDAY  pptx
HERPES SIMPLEX VIRUS 12032019 TUESDAY pptx
 
Neutraceuticals, Herb-drug & Herb-food inetractions
Neutraceuticals, Herb-drug & Herb-food inetractionsNeutraceuticals, Herb-drug & Herb-food inetractions
Neutraceuticals, Herb-drug & Herb-food inetractions
 
Methicillin-resistant Staphylococcus Aureus (MRSA)
Methicillin-resistant Staphylococcus Aureus (MRSA)Methicillin-resistant Staphylococcus Aureus (MRSA)
Methicillin-resistant Staphylococcus Aureus (MRSA)
 
Evolving Concepts in the Pathogenesis of Inflammatory Dermatologic Disorders ...
Evolving Concepts in the Pathogenesis of Inflammatory Dermatologic Disorders ...Evolving Concepts in the Pathogenesis of Inflammatory Dermatologic Disorders ...
Evolving Concepts in the Pathogenesis of Inflammatory Dermatologic Disorders ...
 
Ten lessons learnt as anesthetist.pptx
Ten  lessons  learnt as anesthetist.pptxTen  lessons  learnt as anesthetist.pptx
Ten lessons learnt as anesthetist.pptx
 
Substance use disorder (drug addict ), Addiction
Substance use disorder (drug addict ), AddictionSubstance use disorder (drug addict ), Addiction
Substance use disorder (drug addict ), Addiction
 
Ayurveda research in Hypothyroidism, P
Ayurveda  research  in Hypothyroidism, PAyurveda  research  in Hypothyroidism, P
Ayurveda research in Hypothyroidism, P
 
Tracheostomy .pdf ENT by QuickMedTALK. getting things done on time
Tracheostomy .pdf ENT by QuickMedTALK. getting things done on timeTracheostomy .pdf ENT by QuickMedTALK. getting things done on time
Tracheostomy .pdf ENT by QuickMedTALK. getting things done on time
 
Cholesterol Biosynthesis and catabolism for MBBS, Lab. MEd. BDS.pptx
Cholesterol Biosynthesis  and catabolism for MBBS, Lab. MEd. BDS.pptxCholesterol Biosynthesis  and catabolism for MBBS, Lab. MEd. BDS.pptx
Cholesterol Biosynthesis and catabolism for MBBS, Lab. MEd. BDS.pptx
 
EMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdf
EMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdfEMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdf
EMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdf
 

TOTAL PARENTAL NUTRITION

  • 1. PRESENTED BY ROOMA KHALID M.Phil pharmaceutics(2014- 2016) Islamia University Bahawalpur
  • 2.  Definition  Objectives  Indications  Administration  Formulation  Compounding  Documentation
  • 3.  DEFINITION: A method of feeding the patients by infusing the mixture of all necessary nutrients into the circulatory system, thus by passing the GIT. Also referred to as Intravenous nutrition Parental nutrition
  • 4.  Parental nutrition is indicated generally when there is severe gastro-intestinal dysfunction (patients who cannot take sufficient food or feeding formulas by enteral route)
  • 5. 1:Central or total parental nutrition (TPN) 2:Peripheral parental nutrition (PPN)
  • 6. 1: CENTRAL OR TOTAL PARENTAL NUTRITION: It is given via central vein.central route is indicated when long term feed is anticipated, high tonicity or large volume formulations are required. 2: PERIPHERAL PARENTAL NUTRITION: it is given via peripheral vein. It is indicated for patients which require short term feeding. Generally 900mOsmol/L is maximum osmolarity tolerated by the peripheral veins.
  • 7.  For patients unable to tolerate any form of enteral feeding, the administration of fluid and nutrients via a parenteral route is necessary.  For long-term care a balanced diet containing all the essential nutrients, including vitamins and trace elements, must be provided.
  • 8.  To prevent unwanted weight loss and skin break down, promoting positive nitrogen balance and maintaining visceral and somatic protein stores.  Illness and injury promote catabolism and hypermetabolism, so the patient is burning calories faster to keep up with his body's demands. If he doesn't get adequate nutrition, his body will break down lean muscle for glucose, which could slow healing and prolong his recovery (Collins & Navarre, 2003).
  • 9.  TPN reduces morbidity and mortality, promotes tissue repair, and enhances the immune response (Merck, n.d.)  Johnston at al reported in 1978 that an undernourished patient whose gastrointestinal tract is temporarily or permanently unusable can increase lean body tissue and also lay down fat if fed a suitable combination of nutrients intravenously.
  • 10.  With an understanding of the clinical aspects of TPN, pharmacists can recommend regimens to fulfil the needs of the patient as diagnosed by the physician.  Possible interactions with concomintant medication may be identified and advice given on suitable administration systems.
  • 11. TPN is considered necessary in following conditions:  Patients whose GIT tract is inaccessible, non functional, perforated.  Undernorished patients who cannot ingest larger volumes of oral feedings and are being prepared for surgery, radiation therapy, or chemotherapy.  Disorders requiring complete bowel rest e.g ulcerative colitis
  • 12.  Pediatric GI disorders e.g prolonged diarrhea
  • 13. Powell-Tuck at al reported in 1978 a technique for administration of the total daily requirement for TPN via a single container. This was a significant advance over the multiple-bottle method of administration. Three-litre bag therapy, however, is not ideal for all patients.
  • 14. In an intensive care unit, for example, requirements for fluids and electrolytes may change rapidly throughout the day and require the careful titration that can only be obtained with smaller volume fluids and injections.
  • 15. For short-term therapy rotation of peripheral entry sites may provide a simple means of administering TPN without the complications of initiating central vein access. Silk at al reported in 1983 that for longer-term therapy a catheter placed into the superior vena cava as being the safest method of entry providing rapid dilution of the hypertonic solution.
  • 16. Adult TPN patients generally receive 2-3 litres of fluids per day. Rapid,uncontrolled infusion of this amount of fluid would cause renal overload and would be of no benefit to the patient. It is thus vital that some form of flow control device is employed. This may range from simple clamps through to electronic drip controllers.
  • 17.  Once TPN has been initiated on a patient it is essential that routine monitoring is carried out. The clinical pharmacist should have an understanding of the relevance of these routine tests (particularly those such as 24- hour urine analysis which is the main determinant of nitrogen requirements) in order to make adjustment to the TPN formulation.
  • 18. Parenteral nutrition solutions are complex formulations that generally include energy supplied as dextrose and fat, as well as protein, electrolytes, trace elements,vitamins, and water. These components usually need to be individualized for patients according to their primary diagnosis, chronic diseases, fluid and electrolyte balance,acid-base status, and specific goals of parenteral nutrition.
  • 19. 1. NITROGEN: The main objective of parental nutrition is to supply the undernourished patient with sufficient utilizable nitrogen to re-establish nitrogen balance, i.e. where the amount of nitrogen administered is approximately equal to that excreted (mainly as urea).
  • 20. 2.AMINO ACIDS: The body’s relative requirements of the individual amino acids is expected as follows:  ESSENTIAL: Which cannot be synthesized by man. All the commercially available solutions contain the eight essential amino acids in varying proportions.
  • 21.  NON ESSENTIAL AMINO ACIDS: Those amino acids which can normally be synthesized by the body. These amino acids are used to increase the amount of nitrogen available from the solutions.  SEMI ESSENTIAL AMINO ACIDS: Those amino acids which although they can in theory be synthesized by the body, may occasionally need to be provided in the TPN solution due to the patient's age or disease state.
  • 22. 3.ENERGY MACRO NUTIENTS DEXTROSE:  Dextrose is the primary source of parenteral carbohydrate.  Dextrose is needed by the central nervous system, white blood cells, red blood cells, and renal medulla.  Each gram of hydrated dextrose used in parenteral nutrition yields 3.4 kcal.
  • 23.  Parenteral nutrition solutions suitable for peripheral vein administration have dextrose concentrations of 10% or less.  Parenteral nutrition solutions with final concentrations of 10% or greater must be administered by a central vein because of the high osmolarity.
  • 24. 4. LIPIDS: Administration of lipid emulsion on a daily, twice or three times weekly basis appears to provide a balanced mixture of nutrients for the patient requiring long-term feeding. Intravenous fat emulsions are used in parenteral nutrition as an energy source and to provide essential fatty acids.
  • 25. Intravenous fat emulsions are particularly beneficial as an energy source in patients suffering from diabetes,stress, respiratory acidosis, and hepatic steatosis.
  • 26. 5.ELECTROLYTES:  Electrolytes in maintenance or therapeutic doses need to be added daily to the parenteral nutrition solution to preserve electrolyte homeostasis.  Each patient’s requirements for individual electrolytes depend on the primary disease state, renal function, hepatic function, pharmacotherapy, past intake, renal or extrarenal losses, and nutritional status.
  • 27.  Sodium is of critical importance in the fluid balance of both of healthy and sick subjects.  Sodium losses and gains are generally accompanied by similar shifts in chloride ions and a consequent movement in water.  Severe losses may lead to hypovolaemia, circulatory failure and shock. Generally a serum concentration of 135-145 mEq/litre is throught to be normal.
  • 28.  Potassium is essential for the normal operation of the cell and is an important determinant of cell membrane resting potential.  Thus abnormally high or low levels can result in poor nerve impulse conduction, fluctuations in heart rhythm and even death due to heart failure.  It also plays a vital role in distribution of body water
  • 29.  Absence of calcium from TPN in the long term may produce symptoms of hypocalcaemia such as muscle spasm and numbness.  The effect of lack of calcium on the growing child on TPN could understandably have a dramatic effect of growth and development of bones and teeth.
  • 30. Magnesium has many physiological actions. The most clinically significant effects of magnesium imbalance are associated with changes in neuromuscular or cardiovascular function.
  • 31.  By virtue of its buffering action phosphate helps maintain body acid-base balance.  If phosphate is not provided in the TPN solution hypophosphataemia may develop which can give rise to impaired red blood cell function of many organs.  Hypophosphataemia may also be induced as a result of infusion of high glucose loads.
  • 32.  Trace elements are essential micronutrients that are metabolic cofactors essential for the proper functioning of several enzyme systems.  Zinc, Copper, Selenium, Chromium, Iron, Manganese, Cobalt, Molybdenum.  Zinc requirements are increased in metabolic stress and in gastrointestinal disease secondary to diarrheal diseases.
  • 33.  Manganese and copper are excreted through the biliary tract, whereas Zinc, and selenium are excreted renally.  Therefore, copper and manganese should be used with caution in patients with cholestatic liver disease.
  • 34.  Selenium stores have been shown to be depleted in patients receiving long-term parenteral nutrition or in those with thermal injury, acquired immunodeficiency syndrome, or liver failure.  Therefore, selenium should be added initially to the parenteral nutrition solution for patients with these disease states or conditions.
  • 35. 7. VITAMINS  Patients on long-term TPN therapy will generally require some vitamin supplementation.  The commercial preparations of vitamins available along with recommended daily requirements which seem to vary according to the current available recommendations.
  • 36.  A Retinol  B1 Thiamines  B2 Riboflavine  B6 Pyridoxine  B12 Cyanocobalamin  B Nicotinamide  B Biotin
  • 37.  B Pantothenic acid  B Folic acid  C Ascorbic acid  D Calciferol  E Tocopherol acetate  K Phytomenadione
  • 38.  Vitamins are an essential component of a patient’s daily parenteral nutrition regimen because they are necessary for normal metabolism and cellular function of the body.  Individual parenteral vitamins are recommended when the multivitamins products are not available.
  • 39.  Vitamins that are marketed as single-entity parenteral formulations include  vitamins A, D, E, K, B1 (thiamine), B2 (riboflavin), B3 (niacin), B6 (pyridoxine), B9(folic acid), B12 (cyanocobalamin) , and C (ascorbic acid).
  • 40. 8. FLUIDS  In the human body, water is the predominant chemical entity, generally accounting for more than half of the total body weight.  An inverse relationship exists between the amount of body fat and the amount of body water present in an individual.
  • 41.  Total water gains and losses in the healthy adult fall within the range of 1500-3000ml daily.  Thus, where the patient requires TPN, the volume administered will fall into this range and may need to be supplemented by additional fluids in the special cases of burns, etc.  Careful patient monitoring is required to ensure that they do not become dehydrated.
  • 42.  Nutrients are mixed just prior to infusions, by breaking the plastic connectors between the compartments, then vitamins and trace elements are added extemporaneously to the bag.  Shelf –life of these bags is at least 12 months, but allow only for standardized formulas.  The use of three-compartment TPN bags is less expensive in terms of application costs than separate bottles or hospital- compounded bag systems.
  • 43.  Because of the complexity of parenteral nutrition products, safe preparation is a complicated task.  The quality of the final product depends on the facilities, resources,personnel training and products used in preparation.
  • 44.  Since the inception of parenteral nutrition, pharmacists have developed policies and procedures for parenteral nutrition compounding based on their training and interpretation of the literature.  Parenteral nutrition is considered a high-risk sterile product. Its compounding includes complex and/or numerous aseptic manipulations.
  • 45.  Specific guidelines for aseptic processing include media fill validations of both the process and the personnel carrying out the process.  There are specific requirements for facilities, space and environmental control similar to those of a Class 100 clean-room environment.
  • 46.  Sterile product release checks require visual inspection against a lighted white and black background for evidence of visible particulates or other foreign matter.  In addition,compounding accuracy checks of the addition of all drug products or ingredients used to prepare the parenteral nutrition product are ensured by validating the volume and quantity used in admixture.
  • 47.  Presterilized disposable membrane filtration devices, which are sensitive in detecting low levels of contamination and easy to use, are commercially available.  The compounding of parenteral nutrition admixtures accelerates the rate of physicochemical destabilization, resulting in the recommendation to administer parenteral nutrition as soon after its preparation as possible certain amino acids, lipids, and multivitamins are most susceptible to instability.
  • 48.  Pharmacist involved in TPN should have a thorough understanding of the potential stability issues in these mixtures and be able to advise physicians accordingly.
  • 49.  In general the following information will be required on the label:  Patient name/number  Ward  Product constituents  Batch (dispensing number)  Expiry date/time  Storage conditions
  • 50.  Other instructions such as guidance on administration rate or technique, limitations on further additions etc., may also be required.
  • 51.  Once the product has been filled and labelled a pharmacist should perform a final check against the prescription prior to sending the product to the ward.  This check should include the patient’s name, ward, etc. and should once again compare the constituents requested against the final label.
  • 52.  Details of further additions, storage, conditions, expiry date, etc. should also be confirmed and the batch number or other reference allocated should be checked to facilitate traceability in the event of any difficulties arising subsequent to dispensing, e.g. precipitation, discoloration, etc.
  • 53.  The hospital pharmacist may be involved in development of nursing care guidelines with particular reference to further additions, storage, etc.  It may also be useful for the ward pharmacist to check that TPN is being correctly administered to the patient, i.e. with correct flow control device, away from direct sunlight, etc.
  • 54.  Allwood at al recommends in 1984 that compounded TPN solutions should be stored at 2-8˚C in light of both microbiological and chemical considerations.  Should not be stored at room temperature for periods in excess of the 12-24 hours required for administration.
  • 55.  Where supplies of compounded product are to be made to hospitals or home patients away from the site of manufacture, the quality of the packaging system to maintain product temperature during transit should be validated to the satisfaction of local quality control standards.  Insulated polystyrene containers may be useful for this purpose.
  • 56.  Providing a TPN compounding service within a hospital may be a costly venture for the pharmacy department.  All the factors must be considered when developing true service costs and deciding whether to produce in house or obtain product from a regional hospital or commercial source.
  • 57.  Bags made of poly-ethylene and poly- vinylchloride and of the copolymer ethylenevinylacetate were used as containers of perfusion solutions for total parenteral nutrition.  Injectable solutions for Total Parenteral Nutrition containing L- aminoacids,electrolytes and glucose, are commonly sold as medicinal specialities in glass containers.
  • 58.  Bags made of plastic materials such as copolymer ethylene-vinylacetate (EVA), poly- ethylene (PE) and poly-vinylchloride (PVC) are being used more and more often in the manufacture of containers of perfusion solutions.
  • 59.  A work sheet should be generated for each TPN-dispensing activity to be carried out for recording materials, patient name, label details, etc.  The format for such a work sheet should be agreed between the production and quality control departments of the hospital in accordance with local policy.
  • 60.  Prescribe the nutrient formulation  Recognize the needs of individual patients.  Modification in quantities according to clinical situation of patients.  Monitor the interactions among various electrolytes and drugs affect TPN mixture.  Assist the health care team in developing a cost effective formulary of nutrition products.